Literature DB >> 14015821

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance.

J D BROOME.   

Abstract

A number of the properties of the L-asparaginase present in guinea pig serum have been examined and shown to be indistinguishable from those of the agent responsible for inhibiting cells of lymphoma 6C3HED in vivo. The patterns of instability of the enzyme to changes in temperature and pH were found to parallel closely those of the antilymphoma agent. L-Asparaginase activity was essentially absent from the serum of newborn guinea pigs and this failed to inhibit 6C3HED cells. On separating guinea pig serum proteins by salt precipitation, electrophoresis, and chromatography on DEAE cellulose, antilymphoma activity was found only in fractions which contained L-asparaginase.

Entities:  

Keywords:  ASPARAGINE; LYMPHOMA; PEPTIDE PEPTIDOHYDROLASES

Mesh:

Substances:

Year:  1963        PMID: 14015821      PMCID: PMC2137570          DOI: 10.1084/jem.118.1.99

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Electrophoretic and immunological characteristics of native and purified human growth hormone.

Authors:  S L KAPLAN; M M GRUMBACH
Journal:  Nature       Date:  1962-10-27       Impact factor: 49.962

2.  In vivo and in vitro studies of the action of guinea pig serum against the ascites form of the MurphySturm lymphosarcoma.

Authors:  H AINIS; H M KURTZ; P I KRAMER; H E WEIMER; R M RYAN; E JAMESON
Journal:  Cancer Res       Date:  1958-12       Impact factor: 12.701

3.  Hydrolysis and transfer reactions catalyzed by omega-amidase preparations.

Authors:  A MEISTER; L LEVINTOW; R E GREENFIELD; P A ABENDSCHEIN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

4.  The serum proteins of the fetus and young of some mammals.

Authors:  R A KEKWICK
Journal:  Adv Protein Chem       Date:  1959

5.  Action of guinea pig serum and human gamma globulin on the growth of a rat tumor.

Authors:  H AINIS; E JAMESON; R M RYAN
Journal:  Science       Date:  1956-11-16       Impact factor: 47.728

6.  Action of ribonuclease on certain ascites tumours.

Authors:  L LEDOUX
Journal:  Nature       Date:  1955-02-05       Impact factor: 49.962

7.  Zone electrophoresis in a starch supporting medium.

Authors:  H G KUNKEL; R J SLATER
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

8.  Electrophoresis of proteins on filter paper.

Authors:  H G KUNKEL; A TISELIUS
Journal:  J Gen Physiol       Date:  1951-09       Impact factor: 4.086

9.  Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum.

Authors:  J G KIDD
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

10.  Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. II. Studies on the nature of the active serum constituent: histological mechanism of the regression: tests for effects of guinea pig serum on lymphoma cells in vitro: discussion.

Authors:  J G KIDD
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  53 in total

1.  Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.

Authors:  Meir Wetzler; Ben L Sanford; Joanne Kurtzberg; Divino DeOliveira; Stanley R Frankel; Bayard L Powell; Jonathan E Kolitz; Clara D Bloomfield; Richard A Larson
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

2.  Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4.

Authors:  Reuven J Schore; Meenakshi Devidas; Archie Bleyer; Gregory H Reaman; Naomi Winick; Mignon L Loh; Elizabeth A Raetz; William L Carroll; Stephen P Hunger; Anne L Angiolillo
Journal:  Leuk Lymphoma       Date:  2019-01-10

Review 3.  What makes a good new therapeutic L-asparaginase?

Authors:  Angela Beckett; David Gervais
Journal:  World J Microbiol Biotechnol       Date:  2019-09-24       Impact factor: 3.312

4.  Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.

Authors:  Akito Nakamura; Tadahiro Nambu; Shunsuke Ebara; Yuka Hasegawa; Kosei Toyoshima; Yasuko Tsuchiya; Daisuke Tomita; Jun Fujimoto; Osamu Kurasawa; Chisato Takahara; Ayumi Ando; Ryuichi Nishigaki; Yoshinori Satomi; Akito Hata; Takahito Hara
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

Review 5.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

6.  Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

Authors:  Anne L Angiolillo; Reuven J Schore; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Julie M Gastier-Foster; Nyla A Heerema; Taha Keilani; Ashley R Lane; Mignon L Loh; Gregory H Reaman; Peter C Adamson; Brent Wood; Charlotte Wood; Hao W Zheng; Elizabeth A Raetz; Naomi J Winick; William L Carroll; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

7.  [In vitro studies using E. coli L-asparaginase on lymphatic cells of bovine leukemia and various transplantation tumors].

Authors:  W D Hirschmann; S Seeber; P Warnecke
Journal:  Klin Wochenschr       Date:  1969-11-15

Review 8.  [L-asparaginase and leukemia].

Authors:  E Grundmann
Journal:  Klin Wochenschr       Date:  1969-01-15

Review 9.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

10.  The heterocytotoxicity of human serum. III. Studies of the serum levels and distribution of activity in human populations.

Authors:  G Glumac; A Mates; D Eidinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.